DCM Nouvelle (DCMNVL)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trading below book value: P/B of 0.75 with book value ₹165.30 vs price ₹123.32
• Piotroski F-Score of 7/9 indicates recent financial improvement
• Moderate leverage: Debt/Equity of 0.52 is not excessive
• Promoter holding of 50.11% provides some alignment with minority shareholders
• Sales are still positive at 2.45% growth with latest quarterly revenue of ₹273 Cr

Concerns

• Negative ROE of -5.55% and latest quarter net loss of ₹2 Cr show poor earnings power
• ROCE of only 5.18% means capital is not being employed efficiently
• P/E of 45.96 is expensive on current earnings, and 64.42% profit growth is from a low/weak base
• No dividend yield means shareholders get no cash income while waiting for a turnaround

AI Analysis

Looking at DCM Nouvelle, I see a textbook Graham-style asset play, not a wonderful business. The market prices the share at ₹123.32, while book value stands at ₹165.30 — so I am paying 75 paise for a rupee of net assets. That sounds attractive, but only if those assets can earn money. Today they are not: return on equity is negative at -5.55%, return on capital employed is a weak 5.18%, and the latest quarter delivered a ₹2 Cr net loss on ₹273 Cr of sales. The trailing P/E of 45.96 is almost meaningless for a business making negligible profits; the 64.42% profit growth is from a low base. Sales growth of 2.45% barely keeps pace with inflation, and the 0.00% dividend yield means patient owners receive no cash while waiting. On the positive side, the Piotroski F-Score of 7/9 suggests some recent fundamental improvement, and debt/equity of 0.52 is manageable, not frightening. Promoter holding at 50.11% is respectable. But I cannot call this a moat business; DCM Nouvelle is a commodity-textile operator with weak pricing power. As Graham would say, it is a cigar-butt with maybe a puff or two left. I would want management to demonstrate consistent quarterly profitability and higher ROCE before I get excited. Until then, the discount to book provides a margin of safety only if the assets are honestly valued and liquidation-friendly — something I cannot confirm from these numbers. For an Indian retail investor, this is a speculative asset play, not a compounding machine.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer